News

James Nachtwey Photographs Help Illustrate XDR-TB

This post originally appeared on CNN.com

By Patrice Poltzer for CNN

A mother comforts her young son who is suffering from TB meningitis.
A mother comforts her young son who is suffering from TB meningitis. Photo: James Nachtwey

LONDON, England — Many people think of tuberculosis as being a disease from the past. The truth is far from it: Tuberculosis is mutating into dangerous new strains for which there is no known cure.

One of the most frightening strains is XDR-TB, which stands for extensively drug-resistant TB.

Unlike less virulent strains, XDR-TB does not respond to the antibiotics that are usually used to treat TB. The disease is virtually incurable and threatens to become a pandemic.

About 40,000 new cases of XDR-TB emerge every year, the World Health Organization estimates.

Award-winning photojournalist James Nachtwey, who has chronicled the death and devastation the disease is bringing to many countries around the world, describes XDR-TB as “a merciless, man-eating predator lurking in the shadows.”

He warns: “If it’s not contained, the consequences could be dire.”

Nachtwey, who has been covering humanitarian crises for more than 30 years, was awarded a TED prize in 2007 which gave him $100,000 and one wish to change the world.

His wish centered on spreading awareness of this deadly form of TB and the images are borne out of Nachtwey’s frustrations with the underreporting of what is potentially a global health crisis.

> read the full post at CNN.com

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...